Q2 2025 Sudarshan Chemical Industries Ltd Earnings Call Transcript
Key Points
- Sudarshan Chemical Industries Ltd (BOM:506655) reported a robust growth in top-line with the highest ever pigment sales in Q2 FY25.
- The company achieved a 15% year-on-year increase in total income from operations, reaching INR696 crore.
- EBITDA for the quarter increased significantly to INR94 crore from INR66 crore in Q2 FY24, with margins improving to 13.6%.
- Export revenue showed strong growth, increasing by 44% year-on-year, driven by higher sales in Europe, North America, and Southeast Asia.
- The company's balance sheet strengthened with a reduction in net debt to INR359 crore, improving the leverage ratio to 2.3x.
- The engineering business is dragging overall margins and performance, with no immediate plans to hive it off.
- There is no new incremental CapEx planned, which may limit future growth opportunities.
- Operating leverage is not fully realized as other expenses, including manufacturing and selling costs, remain high.
- The company faces challenges in achieving consistent profitability in the engineering business, with a focus on transformation rather than immediate results.
- There are concerns about potential anti-competitive issues due to the company's significant market share domestically.
Ladies and gentlemen, good day. And welcome to Sudarshan Chemical Industries Limited Q2 FY25 earnings conference call hosted by Dolat Capital.
(Operator Instructions)
I now hand the conference over to Mr. Nitesh Dhoot from Dolat Capital. Thank you and over to you, sir.
Thank you, Steve. Good morning, everyone on behalf of Dolat Capital. I would like to thank the management of Sudarshan Chemical Industries for giving us the opportunity to post their due to FY25 on this conference call. From the management team we have with us today Mr. Rajesh Rathi, Managing Director, Mr. Nilkanth Natu, Chief Financial Officer and Mr. Amey Athalye, General Manager Finance.
Without further ado, I would like to hand over the call to the management for their opening remarks post which we'll open the forum for the Q&A session. Thank you and over to you, sir.
Thank you, Dolat Capital and Mr.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
